These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 31639390

  • 1. Surface Tracking of Curcumin Amorphous Solid Dispersions Formulated by Binary Polymers.
    Fan N, Lu T, Li J.
    J Pharm Sci; 2020 Feb; 109(2):1068-1078. PubMed ID: 31639390
    [Abstract] [Full Text] [Related]

  • 2. Viewing Molecular and Interface Interactions of Curcumin Amorphous Solid Dispersions for Comprehending Dissolution Mechanisms.
    Li J, Wang X, Li C, Fan N, Wang J, He Z, Sun J.
    Mol Pharm; 2017 Aug 07; 14(8):2781-2792. PubMed ID: 28661679
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Advantages of introducing an effective crystalline inhibitor in curcumin amorphous solid dispersions formulated by Eudragit E100.
    Fan N, Li J, Li J.
    J Pharm Pharmacol; 2021 Mar 04; 73(2):185-192. PubMed ID: 33793808
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Effect of HPMCAS/curcumin amorphous solid dispersion in enhancing dissolution and chemical stability of curcumin].
    Liang Q, Wang YR, Deng YY.
    Zhongguo Zhong Yao Za Zhi; 2019 Aug 04; 44(15):3305-3311. PubMed ID: 31602887
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synergetic Role of Hypromellose and Methacrylic Acid Copolymer in the Dissolution Improvement of Amorphous Solid Dispersions.
    Ohyagi N, Ueda K, Higashi K, Yamamoto K, Kawakami K, Moribe K.
    J Pharm Sci; 2017 Apr 04; 106(4):1042-1050. PubMed ID: 27988162
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Storage stability and solubilization ability of HPMC in curcumin amorphous solid dispersions formulated by Eudragit E100.
    Fan N, Ma P, Wang X, Li C, Zhang X, Zhang K, Li J, He Z.
    Carbohydr Polym; 2018 Nov 01; 199():492-498. PubMed ID: 30143154
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Amorphous ternary nanoparticle complex of curcumin-chitosan-hypromellose exhibiting built-in solubility enhancement and physical stability of curcumin.
    Lim LM, Tran TT, Long Wong JJ, Wang D, Cheow WS, Hadinoto K.
    Colloids Surf B Biointerfaces; 2018 Jul 01; 167():483-491. PubMed ID: 29727835
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Experimental and molecular modeling approach to optimize suitable polymers for fabrication of stable fluticasone nanoparticles with enhanced dissolution and antimicrobial activity.
    Ahmed S, Govender T, Khan I, Rehman NU, Ali W, Shah SMH, Khan S, Hussain Z, Ullah R, Alsaid MS.
    Drug Des Devel Ther; 2018 Jul 01; 12():255-269. PubMed ID: 29440875
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions.
    Djuris J, Milovanovic S, Medarevic D, Dobricic V, Dapčević A, Ibric S.
    Int J Pharm; 2019 Jan 10; 554():190-200. PubMed ID: 30414899
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.